Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Vistra appoints Raimundo Diaz as Executive Vice President, Americas, to lead corporate services growth across the region
-
Pasqal Inaugurates Italy’s First Neutral-Atom Quantum Computer, Third Pasqal System in Europe
-
InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures
-
West Texas Resources Issues Spring 2026 Chairman's Letter as Company Advances Toward OTCQB, Expands Operating Capability, and Evaluates High-Impact Gulf Coast Acquisition
-
Michelin | Disclosure of the total number of voting rights and of the number of shares making up the Company’s capital
-
Form 8.3 - Picton Property Income Limited
-
AM General Focuses on Future Driven Capabilities at Eurosatory 2026
-
Form 8.3 - LondonMetric Property Plc & Schroder REIT Ltd
-
Mega Matrix Provides Response to Unusual Market Activity
-
Nova Complex Showcases European Green Infrastructure Strategy at Datacloud Global Congress 2026
-
Chicago Faucets Simplifies the Path to Healthier Showers with the Auto-Drain® Trim Plate for Seamless Retrofits
-
Umbrella Lab Announces Documentation And Traceability Update For Bromantane Reference Material
-
Leading Plastic Surgeons Spotlight "Active Tension Offloading" as Emerging Standard in Surgical Closure at ASAPS
-
3 E Network Enters Strategic Framework Agreement with California-Based Aladdin Alaris AI to Explore Next-Generation Healthcare and Eldercare Robotics
-
Rare Breed® Launches at Chewy with 3-Ingredient, Human-Grade Beef & Pork Treats
-
ACE HARDWARE FRANCHISE OPERATOR BECOMES SECOND U.S. RETAIL PARTNER TO DISTRIBUTE FCL-X™ LITHIUM BATTERY FIRE SUPPRESSION SOLUTION
-
SoCalGas Helps Customers Save More Than $106 Million Through Energy Efficiency Programs
-
Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients
-
Valion Bio (NASDAQ: VBIO) Confirms U.S. House Armed Services Committee Initiative to Address Urgent Need for Radiation /Nuclear Countermeasures
-
Net Asset Value(s)
-
Trust & Will and Fifth Third Mark One Year of Free Wills, $10 Billion in Protected Estate Value, and Hundreds of Thousands of New Customers Ahead
-
The Edge Negotiation Group Launches Deal/Spar, an AI-Powered Negotiation Simulator for Voice and Text-Based Practice
-
The Hemp Tax: Why Industrial Hemp Can’t Afford to Sit This One Out[
-
Baystate Franklin Nurses Vote 98% to Reject Inadequate "Best and Final" Offer in Push for Contract that Protects Safe, Local Patient Care
-
Wyss Geneva Steps Into Its Next Chapter
-
Porter Takes off With New Service Between Ottawa and Deer Lake
-
Omdia: Netflix to Reach 400 Million Subscribers by 2031, Maintaining Global Streaming Lead Despite Industry Consolidation
-
NovaRed Mining Provides Summary of Results for Wilmac Copper-Gold Project
-
SAGA Metals Reports Assays from R-0044 to R-0046 with Intercepts Including 58.33% Fe2O3, 8.78% TiO2, 0.415% V2O5 from 2026 Drilling at Trapper South, Radar Critical Minerals Project in Labrador
-
Pacifica Silver Reports Strong Gold-Silver Intercepts at Claudia Project and Extends Justina Vein to 600 Metres in Strike Length
-
Metals Creek Continues to See Encouraging Visuals in Third Drill Hole at the Ogden Gold Project, Completes Drill Program
-
ESGold Receives Dore Melting Furnace at Montauban Project Site
-
Coram AI Raises $35 Million Series B to Accelerate the Future of AI-Native Physical Security
-
UNLOCKD Reports 76% Month-Over-Month Revenue Growth at Ancient Extracts Following Acquisition
-
Midland Identifies Several Lake Bottom Copper Anomalies from Its New High-Resolution Survey Completed on the Lac Bernard Project
-
Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer
-
Tris Pharma to Present on Dual NOP/MOP Receptor Agonist in Pain Management and Substance Use Disorder at the College on Problems of Drug Dependence (CPDD) 88th Annual Scientific Meeting, 2026
-
North American Niobium to Fly Airborne Survey Over Four Québec Properties
-
FLUENT Provides Management Update
-
NEUPATH HEALTH ANNOUNCES VOTING RESULTS FROM THE ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
-
Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera
-
Krya Global Solutions expands U.S. presence to strengthen Background Screening Services
-
QGold Provides Update on Acceleration of Warrants
-
Immunome Announces First Patient Dosed in Phase 1 Trial Evaluating IM-1617, a Potential First-in-Class ADC, in Patients with Advanced Solid Tumors
-
Spinach® is the Number One Vape Brand in Canada
-
Brixton Metals Commences 2026 Thorn Project Exploration Program
-
Medicus Pharma Initiates Groundbreaking PRECISION-E2 Phase 2a Study of Teverelix® in Endometriosis utilizing the Emirati Genome Program
-
Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results
-
Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference
-
Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer
